Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Safety and Efficacy of Vonoprazan vs Proton Pump Inhibitor With Vitamin D or Probiotics Based Triple Therapy for Eradication of Helicobacter Pylori Infection

NCT07293910 is registered in ClinicalTrials.gov with Tanta University as lead sponsor.

NCT NCT07293910
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07293910 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Safety and Efficacy of Vonoprazan vs Proton Pump Inhibitor With Vitamin D or Probiotics Based Triple Therapy for Eradication of Helicobacter Pylori Infection
Lead sponsor
Tanta University
Phase
Phase 2
Overall status
Recruiting
Start date
February 15, 2026
Completion date
December 20, 2026
Enrollment
132 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

helicobacter infection, helicobacter pylori gastrointestinal tract infection, helicobacter pylori infected patients, helicobacter pylori infections